Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability
Tyrosine kinase inhibitors (TKIs) can inhibit edema and neovascularization, such as in age-related macular degeneration and diabetic retinopathy. However, their